Comparative Study of Different H 2 S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage.
Elisabetta MariniBarbara RolandoFederica SodanoFederica BluaGiulia ConcinaStefano GuglielmoLoretta LazzaratoKonstantin ChegaevPublished in: Antioxidants (Basel, Switzerland) (2023)
In the last years, research proofs have confirmed that hydrogen sulfide (H 2 S) plays an important role in various physio-pathological processes, such as oxidation, inflammation, neurophysiology, and cardiovascular protection; in particular, the protective effects of H 2 S in cardiovascular diseases were demonstrated. The interest in H 2 S-donating molecules as tools for biological and pharmacological studies has grown, together with the understanding of H 2 S importance. Here we performed a comparative study of a series of H 2 S donor molecules with different chemical scaffolds and H 2 S release mechanisms. The compounds were tested in human serum for their stability and ability to generate H 2 S. Their vasorelaxant properties were studied on rat aorta strips, and the capacity of the selected compounds to protect NO-dependent endothelium reactivity in an acute oxidative stress model was tested. H 2 S donors showed different H 2 S-releasing kinetic and produced amounts and vasodilating profiles; in particular, compound 6 was able to attenuate the dysfunction of relaxation induced by pyrogallol exposure, showing endothelial protective effects. These results may represent a useful basis for the rational development of promising H 2 S-releasing agents also conjugated with other pharmacophores.
Keyphrases
- type diabetes
- oxidative stress
- diabetic rats
- cardiovascular disease
- endothelial cells
- hydrogen peroxide
- high glucose
- drug induced
- dna damage
- induced apoptosis
- liver failure
- ischemia reperfusion injury
- kidney transplantation
- aortic dissection
- nitric oxide
- respiratory failure
- aortic valve
- photodynamic therapy
- pulmonary artery
- single molecule
- case control
- metabolic syndrome
- intensive care unit
- pulmonary hypertension
- hepatitis b virus
- cardiovascular events
- pulmonary arterial hypertension
- coronary artery disease
- solid state
- visible light
- plant growth